Caricamento...
Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis
Activation of antigen-specific T-lymphocyte responses may be needed to cure disorders caused by chronic infection with low-risk human papillomavirus (lrHPV). Safe and effective adjuvant therapies for such disorders are needed. The safety and efficacy of a novel gorilla adenovirus vaccine expressing...
Salvato in:
| Pubblicato in: | NPJ Vaccines |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8213691/ https://ncbi.nlm.nih.gov/pubmed/34145272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-021-00348-x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|